EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Impact of Infections During Pregnancy on Transplacental Antibody Transfer

Celeste Coler, Elana King-Nakaoka, Emma Every, Sophia Chima, Ashley Vong, Briana Del Rosario, Roslyn VanAbel, Kristina M Adams Waldorf iD

Vaccines · 21.10.2024 · 12 (10) · 1199

DOI: 10.3390/vaccines12101199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 21.10.2024. Verfasst von Celeste Coler und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Washington, Seattle, WA 98195, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination in pregnancy is important to protect the mother and fetus from infectious diseases. The transfer of maternal antibodies across the placenta during pregnancy can continue to protect the neonate for several months after birth while the neonatal adaptive immune system develops. Several pathogens have been shown to impair the transplacental transfer of maternal antibodies, including human immunodeficiency virus, malaria, the severe acute respiratory syndrome coronavirus 2, and cytomegalovirus. This review discusses the mechanisms contributing to decreased transplacental antibody transfer in the setting of maternal infections, such as changes in antibody glycosylation profile, maternal hypergammaglobulinemia, and placental injury. The frequency of epidemics is increasing, and pregnant people are more likely to become exposed to novel pathogens now than they were in the past. Understanding the mechanisms by which infectious diseases impair maternal–fetal antibody transfer is important for pandemic preparedness to maximize the impact of maternal vaccination for child health.

Schlagwörter

Stichwörter der Autor:innen

HIVSARS-CoV-2antibodyfetusmalariaplacentapregnancyvaccine

Autor:innen und Institutionen

  • School of Medicine, University of Washington, Seattle, WA 98195, USA.
  • Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.
  • Department of Global Health, University of Washington, Seattle, WA 98105, USA.
  • College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.

ORCID-Profile: Kristina M Adams Waldorf

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NCRR NIH HHS
  • National Institutes of Health
  • Infectious Disease Society of America
  • Curci Ph.D. Scholars Program

Zitieren

APA

Coler, C., King-Nakaoka, E., Every, E., Chima, S., Vong, A., Del Rosario, B., VanAbel, R., & Adams Waldorf, K. M. (2024). Impact of Infections During Pregnancy on Transplacental Antibody Transfer. Vaccines, 12(10), 1199. https://doi.org/10.3390/vaccines12101199

Vancouver

Coler C, King-Nakaoka E, Every E, Chima S, Vong A, Del Rosario B, et al. Impact of Infections During Pregnancy on Transplacental Antibody Transfer. Vaccines. 2024;12(10):1199. doi:10.3390/vaccines12101199

BibTeX
@article{Coler2024,
  author = {Coler, Celeste and King-Nakaoka, Elana and Every, Emma and Chima, Sophia and Vong, Ashley and Del Rosario, Briana and VanAbel, Roslyn and Adams Waldorf, Kristina M},
  title = {Impact of Infections During Pregnancy on Transplacental Antibody Transfer},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {1199},
  doi = {10.3390/vaccines12101199}
}
Kostenlos starten →